ArticleFrontiers in medicine2026
Clinical risk factors and machine learning for venous thromboembolism in lung cancer: an exploratory single-center study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Venous thromboembolism (VTE) represents a common and severe comorbidity in lung cancer patients. This study aimed to characterize the clinical features and independent risk factors associated with VTE in these individuals, and to evaluate the complementary utility of machine learning approaches in enhancing VTE risk stratification. Methods: This retrospective study included lung cancer patients admitted to the Fourth Affiliated Hospital of Anhui Medical University between January 2018 and April 2025. According to imaging findings, patients were categorized into a VTE group and a control group. Clinical characteristics, laboratory parameters, and treatment-related information were retrospectively collected and analyzed. Univariate and multivariable logistic regression analyses were performed to identify factors independently associated with VTE. Additionally, four machine learning models-Ridge-LR, LASSO, random forest (RF), and extreme gradient boosting (XGBoost)-were developed for exploratory purposes. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), sensitivity, specificity, calibration metrics (Brier score, calibration slope and intercept, Hosmer-Lemeshow test), and decision curve analysis (DCA). Results: A total of 180 patients with lung cancer were included. Elevated D-dimer levels were independently associated with increased VTE risk (OR = 1.084, Conclusion: Elevated D-dimer levels measured prior to VTE diagnosis during routine clinical monitoring were independently associated with subsequent VTE, supporting its potential utility as a predictive biomarker for risk stratification in patients with lung cancer. The association between chemotherapy exposure and VTE is likely influenced by selection bias and residual confounding rather than representing a true causal effect. Machine learning models did not demonstrate consistent improvement over logistic regression in discrimination or calibration in this small single-center cohort, suggesting limited added predictive value with the current dataset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.